Trial intelligence / Profile preview

Effect of domperidone on plasma glucose levels and 24-hour glucose variability in type 1 diabetes

2009-009436-69Phase 4Active

Sponsor
Danderyds sjukhus
Start
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of domperidone in diabetes mellitus type 1 (T1D), sponsored by Danderyds sjukhus. Primary endpoint: Glucose variability (primary). Started Sep 2009; status: active.

02

Drugs

domperidone
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2009-009436-69.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-009436-69.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call